Healthcare
Sedentary Behavior Linked to Higher Cardiac Event Risk After Hospitalization
A new study reveals that prolonged sedentary time increases the risk of subsequent cardiac events within a year after hospitalization. Replacing sitting time with light physical activity or sleep can significantly reduce cardiovascular risks.
Calidi Biotherapeutics Appoints Experienced Life Science Leader Eric Poma as New CEO
Calidi Biotherapeutics has named Dr. Eric Poma as its new Chief Executive Officer, bringing over 30 years of life science expertise to guide the company's innovative cancer therapy development strategy.
Plastic Surgeon Dr. Rian Maercks Unveils Advanced Midface Lifting Technique
Dr. Rian Maercks challenges traditional facial rejuvenation methods by introducing a sophisticated deep-plane surgical technique that prioritizes natural aesthetic outcomes and minimal recovery time, offering patients a nuanced approach to facial enhancement.
Aditxt Terminates Acquisition Agreement with Appili Therapeutics
Aditxt Inc. has decided to end its planned acquisition of Appili Therapeutics, citing a lack of strategic alignment. The termination highlights potential challenges in healthcare innovation partnerships.
DarioHealth Receives Bullish Rating with $3 Price Target, Signaling Potential 350% Growth
Litchfield Hills Research initiates a Buy rating for DarioHealth, projecting substantial growth potential based on the company's strategic B2B2C transformation, multi-condition digital health platform, and strong market positioning in chronic care management.
Multimodal AI System Promises More Accurate Lung Cancer Screening
A new AI technology demonstrates potential to dramatically improve lung cancer detection by reducing false-positive rates and providing more comprehensive diagnostic insights. This advancement could significantly impact early disease identification and patient outcomes.
CNS Pharmaceuticals Advances Brain Cancer Treatment, Reports Q1 Financial Results
CNS Pharmaceuticals is progressing its brain cancer treatment TPI 287, with increased R&D spending and plans for a Phase 2 study in recurrent glioblastoma multiforme, while maintaining financial runway into 2026.
NanoViricides Advances Broad-Spectrum Antiviral Drug, Eyes Multiple Phase II Trials
NanoViricides is progressing its NV-387 drug candidate across multiple viral infections, with pending Phase II trials for MPox and emerging programs for measles and avian flu, highlighting significant potential in antiviral treatment development.
Cass Dental Opens New St. Albert Location, Welcomes Community Back
Dr. Cassandra Phillips returns to dental practice with a new clinic in St. Albert, bringing together an experienced team to provide personalized dental care. The new location marks a significant moment for long-time patients and the local community.
Adageis Launches AI-Powered Platform to Revolutionize Healthcare Financial Management
Adageis introduces an innovative fintech platform designed to help medical practices navigate value-based care more efficiently, leveraging AI to improve clinical and financial performance for smaller healthcare providers.
Nutriband Expands Pharma Footprint with Strategic Partnerships
Nutriband Inc. strengthens its market position through strategic alliances with Charlotte FC and Kindeva Drug Delivery, focusing on its innovative abuse-deterrent transdermal drug delivery technology.
Soligenix Advances Phase 3 Trial for Cutaneous T-Cell Lymphoma Treatment, Zacks Report Shows Promise
Soligenix continues enrollment in its Phase 3 HyBryte trial for cutaneous T-cell lymphoma, with Zacks Research highlighting the trial's high potential for success and anticipated topline results in 2026.
Telomir Pharmaceuticals Reveals Innovative Silver(II) Antimicrobial Drug Candidate
Telomir Pharmaceuticals has developed Telomir-Ag2, a novel Silver(II) complex with broad-spectrum antimicrobial properties targeting significant medical markets including wound care and infection treatment.
Trump's Executive Order on Drug Prices: Uncertainty Looms
President Trump's executive order targeting prescription drug prices raises questions about implementation and potential economic impacts. The order's effectiveness and long-term consequences remain unclear.
Calidi Biotherapeutics Advances Cancer Immunotherapy Platform, Reduces Quarterly Losses
Calidi Biotherapeutics has made significant progress in its oncology research, receiving FDA clearance for a stem cell-based immunotherapy and presenting promising data on its Redtail virotherapy platform while simultaneously reducing operational expenses.
NextPlat Corp Reports Q1 Revenue of $14.5M, Navigates Healthcare Market Challenges
NextPlat Corp's Q1 2025 financial results reveal strategic adjustments in the e-commerce and healthcare sectors, with a focus on high-margin services despite revenue decline and market headwinds.
NextPlat Corp Reports Q1 Revenue Decline, Maintains Strategic Healthcare Focus
NextPlat Corp experienced a revenue decrease in Q1 2025 but demonstrated strategic resilience by expanding e-commerce operations and maintaining a focus on high-margin healthcare services.
New Study Suggests Combining Fluoride and Iodine Could Enhance Cavity Prevention
A recent study reveals that using fluoride and iodine together may significantly reduce tooth decay in children, potentially offering a more effective approach to dental care than fluoride treatment alone.
Advocacy Group Launches National Campaign to Reform 340B Drug Pricing Program
ADAP Advocacy initiates a nationwide campaign questioning the accountability and transparency of the 340B Drug Pricing Program, drawing parallels to pre-2008 financial market oversight and highlighting potential systemic issues in healthcare.
Icarus Behavioral Health Launches Comprehensive Mental Health and Addiction Treatment Center in Boise
Icarus Behavioral Health Idaho opens a new Joint Commission-accredited treatment facility in Boise, offering comprehensive mental health and addiction treatment services with a range of specialized programs and evidence-based therapies.
Local Medicare Insurance Expert Transforms Personal Loss into Healthcare Advocacy
Doreen Dann, a licensed health insurance agent, shares her journey of turning a personal Medicare enrollment challenge into a mission of helping clients navigate complex insurance landscapes, highlighting the importance of informed healthcare decision-making.
Creative Biolabs Advances Antibody Engineering with Innovative Glycosylation Technology
Creative Biolabs has developed a sophisticated analytical platform for monoclonal antibody glycan profiling, enhancing therapeutic antibody effectiveness through precise Fc region modifications. These technological improvements could significantly impact biopharmaceutical drug development.
GoHealth Reports Strong Q1 Performance, Launches Life Insurance Offering
GoHealth Inc. demonstrates significant growth in Q1 2025 with a 19.1% revenue increase and the strategic launch of GoHealth Protect, signaling potential diversification and market expansion in the digital health insurance space.
Tevard's tRNA Therapy Offers Promising Approach to Duchenne Muscular Dystrophy Treatment
Tevard Biosciences demonstrated a breakthrough in treating Duchenne Muscular Dystrophy by restoring full-length dystrophin protein using suppressor tRNA therapy, potentially offering hope for patients with nonsense mutations.
NanoViricides Advances Promising Antiviral Drug Against Measles and MPox
NanoViricides is developing NV-387, a potential breakthrough treatment for Measles and MPox amid rising global case counts and limited medical interventions. The drug represents a critical advancement in addressing urgent infectious disease challenges.
IntusCare Launches Innovative Electronic Medical Record System for PACE Organizations
PACE Organization of Rhode Island becomes the first healthcare provider to implement IntusCare's CareHub, a specialized electronic medical record and practice management platform designed specifically for Programs of All-Inclusive Care for the Elderly.
Silo Pharma Advances PTSD Treatment with FDA-Requested Safety Study
Silo Pharma is conducting a critical safety study on its intranasal PTSD treatment SPC-15, which could potentially provide a new therapeutic option for patients struggling with stress-related disorders by meeting FDA requirements for clinical advancement.
Viral TikTok Video Highlights Simple Hand Motion Test for Potential Brain Tumor Detection
A social media trend reveals a 30-second hand test that could help individuals identify potential undiagnosed brain health issues, raising awareness about early symptom recognition.
Tonix Pharmaceuticals Bolsters Leadership with Experienced Executive Joseph Hand
Tonix Pharmaceuticals strengthens its executive team by appointing Joseph Hand as General Counsel and EVP of Operations, bringing extensive corporate experience ahead of a potential FDA approval for its fibromyalgia treatment.
HeartBeam Advances Cardiac Care Technology with FDA Milestone and Strategic Partnerships
Medical technology company HeartBeam achieved significant progress in Q1 2025, completing a pivotal study for its 12-lead ECG synthesis software and expanding strategic partnerships while raising crucial funding for commercialization.